These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 3262671

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activation of Lyt-2+ (CD8+) and L3T4+ (CD4+) T cell subsets by anti-receptor antibody.
    Hathcock KS, Segal DM, Hodes RJ.
    J Immunol; 1989 Apr 01; 142(7):2181-6. PubMed ID: 2784455
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL, Havran WL, Nau GJ, Lancki DW, Kim DK, Fitch FW.
    J Immunol; 1987 Aug 01; 139(3):657-64. PubMed ID: 2955046
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt-Verhulst AM, Pierres M.
    J Immunol; 1984 Jun 01; 132(6):2775-82. PubMed ID: 6202760
    [Abstract] [Full Text] [Related]

  • 8. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S, Yang Y, Sadegh-Nasseri S, Ashwell JD.
    J Immunol; 1993 Mar 15; 150(6):2211-21. PubMed ID: 8450208
    [Abstract] [Full Text] [Related]

  • 9. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL, Fitch FW.
    J Immunol; 1988 Sep 15; 141(6):1808-12. PubMed ID: 2459190
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deviations in thymocyte development induced by divalent and monovalent ligation of the alpha/beta T cell receptor and by its cross-linking to CD8.
    Yachelini P, Falk I, Eichmann K.
    J Immunol; 1990 Sep 01; 145(5):1382-9. PubMed ID: 1974566
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunoregulation through CD8 (Ly-2): state of aggregation with the alpha/beta/CD3 T cell receptor controls interleukin 2-dependent T cell growth.
    Jönsson JI, Boyce NW, Eichmann K.
    Eur J Immunol; 1989 Feb 01; 19(2):253-60. PubMed ID: 2495222
    [Abstract] [Full Text] [Related]

  • 16. Functional responsiveness in vitro and in vivo of alpha/beta T cell receptors expressed by the B2A2 (J11d)- subset of CD4-8- thymocytes.
    Howe RC, Pedrazzini T, MacDonald HR.
    Eur J Immunol; 1989 Jan 01; 19(1):25-30. PubMed ID: 2784108
    [Abstract] [Full Text] [Related]

  • 17. Characterization of an anti-Ly-6 monoclonal antibody which defines and activates cytolytic T lymphocytes.
    Havran WL, Lancki DW, Moldwin RL, Dialynas DP, Fitch FW.
    J Immunol; 1988 Feb 15; 140(4):1034-42. PubMed ID: 3257767
    [Abstract] [Full Text] [Related]

  • 18. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R, Vandenberghe P, Craighead N, Smoot DS, Lee KP, June CH.
    J Immunol; 1995 Feb 01; 154(3):985-97. PubMed ID: 7822814
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.